• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卫生政策与痴呆。

Health Policy and Dementia.

机构信息

Albert Einstein College of Medicine, Bronx, NY, USA.

出版信息

Curr Psychiatry Rep. 2018 Feb 1;20(1):4. doi: 10.1007/s11920-018-0868-0.

DOI:10.1007/s11920-018-0868-0
PMID:29387967
Abstract

PURPOSE OF REVIEW

The anticipated number of persons with dementia continues to grow, and the US has insufficiently planned to provide and pay for care for this large population.

RECENT FINDINGS

A number of significant clinical trials aiming to prevent or cure dementia, including Alzheimer's disease, have not demonstrated success. Because of the lack of efficacious treatments, and the fact that brain changes associated with dementia may begin decades before symptoms, we can predict that efforts to cure or prevent dementia will not succeed in time for millions of people in the baby boomer generation. Because of the anticipated increase in people suffering with dementia in the coming years, US health policy must address major gaps in how to provide and pay for dementia care. Reliance on Medicaid and Medicare as currently structured will not sustain the necessary care, nor can families alone provide all necessary dementia care. Innovative forms of providing long-term care and paying for it are crucially needed.

摘要

目的综述

预计患有痴呆症的人数还在持续增长,而美国为这一庞大群体提供和支付护理服务的计划严重不足。

最新发现

多项旨在预防或治疗痴呆症(包括阿尔茨海默病)的重要临床试验并未取得成功。由于缺乏有效的治疗方法,而且与痴呆症相关的大脑变化可能在出现症状前几十年就已经开始,我们可以预测,治疗或预防痴呆症的努力将无法及时惠及数百万婴儿潮一代的人。由于未来几年预计会有更多的人患有痴呆症,美国的医疗政策必须解决在提供和支付痴呆症护理服务方面存在的重大差距。单纯依赖目前的医疗补助和医疗保险结构,将无法维持必要的护理服务,而家庭也无法独自提供所有必要的痴呆症护理。迫切需要创新形式来提供长期护理并为之付费。

相似文献

1
Health Policy and Dementia.卫生政策与痴呆。
Curr Psychiatry Rep. 2018 Feb 1;20(1):4. doi: 10.1007/s11920-018-0868-0.
2
The politics and policies of caring for the elderly in an age of retrenchment: a symposium, Part 2.紧缩时代的养老政治与政策:研讨会,第二部分
J Health Hum Serv Adm. 2000 Fall;23(2):127-35.
3
Double jeopardy: the challenge of providing mental health services to older persons.双重困境:为老年人提供心理健康服务的挑战。
Adm Policy Ment Health. 1998 Sep;26(1):65-74. doi: 10.1023/a:1021221521030.
4
Long-term care in the United States: policy themes and promising practices.美国的长期护理:政策主题与可行做法
J Gerontol Soc Work. 2010 Jan;53(1):43-63. doi: 10.1080/01634370903361979.
5
The availability of long-term care services for Medicare beneficiaries in health maintenance organizations.健康维护组织中为医疗保险受益人提供的长期护理服务的可获得性。
Med Care. 1988 Sep;26(9):918-25. doi: 10.1097/00005650-198809000-00010.
6
Qualitative analysis of the Program of All-inclusive Care for the Elderly (PACE).老年人全面护理计划(PACE)的定性分析。
Gerontologist. 1992 Dec;32(6):771-80. doi: 10.1093/geront/32.6.771.
7
Public policy toward special dementia care units.针对特殊痴呆症护理单元的公共政策。
Alzheimer Dis Assoc Disord. 1994;8 Suppl 1:S405-7.
8
Medicare for people with Alzheimer's disease.为患有阿尔茨海默病的人提供医疗保险。
Issue Brief Cent Medicare Educ. 2004;5(8):1-6.
9
Long-term care: the Australian experience.长期护理:澳大利亚的经验
Health Care Manag. 1997 Jun;3(1):157-65.
10
PACE community care & more. Integrated care program offers opportunities for providers seeking alternatives.PACE社区护理及更多服务。综合护理项目为寻求替代方案的提供者提供了机会。
Provider. 2003 Jun;29(6):40-4.

引用本文的文献

1
Drawing the mind: assessing cognitive decline through self-figure drawings.描绘心灵:通过自画像评估认知衰退
Front Psychol. 2025 May 7;16:1558675. doi: 10.3389/fpsyg.2025.1558675. eCollection 2025.
2
Does Dementia Have a Microbial Cause?痴呆症有微生物病因吗?
NeuroSci. 2022 May 17;3(2):262-283. doi: 10.3390/neurosci3020019. eCollection 2022 Jun.
3
Sex Differences in Healthcare Utilization in Persons Living with Dementia Between 2000 and 2017: A Population-Based Study in Quebec, Canada.2000年至2017年痴呆症患者医疗保健利用情况的性别差异:加拿大魁北克省的一项基于人群的研究

本文引用的文献

1
Highly active antiretroviral therapy for critically ill HIV patients: A systematic review and meta-analysis.针对重症HIV患者的高效抗逆转录病毒治疗:一项系统评价与荟萃分析。
PLoS One. 2017 Oct 24;12(10):e0186968. doi: 10.1371/journal.pone.0186968. eCollection 2017.
2
Classics in Chemical Neuroscience: Memantine.化学神经科学经典著作:盐酸美金刚。
ACS Chem Neurosci. 2017 Sep 20;8(9):1823-1829. doi: 10.1021/acschemneuro.7b00270. Epub 2017 Aug 9.
3
A National Profile Of End-Of-Life Caregiving In The United States.美国的临终关怀护理国家概况。
J Aging Health. 2025 Mar;37(3-4):243-254. doi: 10.1177/08982643241242512. Epub 2024 Mar 30.
4
Racial and Ethnic Disparities in Serious Psychological Distress Among Those With Alzheimer's Disease and Related Dementias.在患有阿尔茨海默病和相关痴呆症的人群中,严重心理困扰的种族和民族差异。
Am J Geriatr Psychiatry. 2020 Apr;28(4):478-490. doi: 10.1016/j.jagp.2019.08.010. Epub 2019 Aug 15.
Health Aff (Millwood). 2017 Jul 1;36(7):1184-1192. doi: 10.1377/hlthaff.2017.0134.
4
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.成人急性髓系白血病的诊断与管理:2017年国际专家小组的欧洲白血病网络(ELN)建议
Blood. 2017 Jan 26;129(4):424-447. doi: 10.1182/blood-2016-08-733196. Epub 2016 Nov 28.
5
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.无痴呆症人群中脑淀粉样病变的患病率:一项荟萃分析。
JAMA. 2015 May 19;313(19):1924-38. doi: 10.1001/jama.2015.4668.
6
The Elderhaus Program of All-inclusive Care for the Elderly in North Carolina: improving functional outcomes and reducing cost of care: preliminary data.北卡罗来纳州老年人全包式护理的埃尔德豪斯项目:改善功能结局并降低护理成本:初步数据
J Am Geriatr Soc. 2015 Mar;63(3):578-83. doi: 10.1111/jgs.13249. Epub 2015 Mar 6.
7
Alzheimer's disease drug-development pipeline: few candidates, frequent failures.阿尔茨海默病药物研发管线:候选药物寥寥,失败频频。
Alzheimers Res Ther. 2014 Jul 3;6(4):37. doi: 10.1186/alzrt269. eCollection 2014.
8
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.两项评估 bapineuzumab 治疗轻度至中度阿尔茨海默病的 3 期临床试验。
N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.
9
Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease.用于轻中度阿尔茨海默病的 solanezumab 的 3 期临床试验。
N Engl J Med. 2014 Jan 23;370(4):311-21. doi: 10.1056/NEJMoa1312889.
10
Development times, clinical testing, postmarket follow-up, and safety risks for the new drugs approved by the US food and drug administration: the class of 2008.2008 年批准的新药的研发时间、临床测试、上市后随访和安全风险:美国食品和药物管理局的分类。
JAMA Intern Med. 2014 Jan;174(1):90-5. doi: 10.1001/jamainternmed.2013.11813.